These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25418950)

  • 1. Do not drop: mechanical shock in vials causes cavitation, protein aggregation, and particle formation.
    Randolph TW; Schiltz E; Sederstrom D; Steinmann D; Mozziconacci O; Schöneich C; Freund E; Ricci MS; Carpenter JF; Lengsfeld CS
    J Pharm Sci; 2015 Feb; 104(2):602-11. PubMed ID: 25418950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Container Surfaces Control Initiation of Cavitation and Resulting Particle Formation in Protein Formulations After Application of Mechanical Shock.
    Wu H; Chisholm CF; Puryear M; Movafaghi S; Smith SD; Pokhilchuk Y; Lengsfeld CS; Randolph TW
    J Pharm Sci; 2020 Mar; 109(3):1270-1280. PubMed ID: 31758950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Effect of Cavitation and Agitation on Protein Aggregation.
    Torisu T; Maruno T; Hamaji Y; Ohkubo T; Uchiyama S
    J Pharm Sci; 2017 Feb; 106(2):521-529. PubMed ID: 27887723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameters Influencing Cavitation Within Vials Subjected to Drop Shock.
    Valotta Rodrigues R; Puryear M; Sederstrom D; Lengsfeld CS
    Sci Rep; 2019 Dec; 9(1):19210. PubMed ID: 31844126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Container Surface Passivation on Aggregation of Intravenous Immunoglobulin Induced by Mechanical Shock.
    Movafaghi S; Wu H; Francino Urdániz IM; Bull DS; Kelly MD; Randolph TW; Goodwin AP
    Biotechnol J; 2020 Sep; 15(9):e2000096. PubMed ID: 32437086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.
    Kalonia C; Kumru OS; Prajapati I; Mathaes R; Engert J; Zhou S; Middaugh CR; Volkin DB
    J Pharm Sci; 2015 Feb; 104(2):536-47. PubMed ID: 25302696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
    Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
    J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogel Coatings on Container Surfaces Reduce Protein Aggregation Caused by Mechanical Stress and Cavitation.
    Movafaghi S; Daniels AL; Kelly MD; Witeof AE; Calderon CP; Randolph TW; Goodwin AP
    ACS Appl Bio Mater; 2021 Sep; 4(9):6946-6953. PubMed ID: 35006994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation and Particle Formation of Therapeutic Proteins in Contact With a Novel Fluoropolymer Surface Versus Siliconized Surfaces: Effects of Agitation in Vials and in Prefilled Syringes.
    Teska BM; Brake JM; Tronto GS; Carpenter JF
    J Pharm Sci; 2016 Jul; 105(7):2053-65. PubMed ID: 27233685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.
    Nishi H; Mathäs R; Fürst R; Winter G
    J Pharm Sci; 2014 Jan; 103(1):90-9. PubMed ID: 24218205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution.
    Nayak A; Colandene J; Bradford V; Perkins M
    J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
    Barnard JG; Singh S; Randolph TW; Carpenter JF
    J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effect of syringe surfaces on protein formulations.
    Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
    J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The missing piece in the puzzle: Prediction of aggregation via the protein-protein interaction parameter A
    Koepf E; Schroeder R; Brezesinski G; Friess W
    Eur J Pharm Biopharm; 2018 Jul; 128():200-209. PubMed ID: 29723667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation and Particle Formation During Pumping of an Antibody Formulation Are Controlled by Electrostatic Interactions Between Pump Surfaces and Protein Molecules.
    Wu H; Randolph TW
    J Pharm Sci; 2020 Apr; 109(4):1473-1482. PubMed ID: 32004539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microflow Imaging Analyses Reflect Mechanisms of Aggregate Formation: Comparing Protein Particle Data Sets Using the Kullback-Leibler Divergence.
    Maddux NR; Daniels AL; Randolph TW
    J Pharm Sci; 2017 May; 106(5):1239-1248. PubMed ID: 28159641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfaces Affect Screening Reliability in Formulation Development of Biologics.
    Zidar M; Posnjak G; Muševič I; Ravnik M; Kuzman D
    Pharm Res; 2020 Jan; 37(2):27. PubMed ID: 31907628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.